Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover EEC study of TAC-202 (bilastine) vs placebo and fexofenadine in Japanese cedar pollinosis
jRCT2080222167Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bilastine in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
bilastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCT2080222167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222167.